Thrombocytopenia in pregnancy: is this immune thrombocytopenia or...?
Hematology Am Soc Hematol Educ Program., 2012:198-202 (2012)
Transfusion-associated graft-versus-host disease in a liver transplant recipient: an unusual presentation and review of the literature.
Transfusion., May (2012)
RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME).
Transfusion., May;52(5):1126-36; quiz 1125 (2012)
Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia.
Blood., May;117(21):5723-32 (2011)
Dose of prophylactic platelet transfusions and prevention of hemorrhage.
N. Engl. J. Med., Feb;362(7):600-13 (2010)
Thrombopoietin and platelet production in chronic immune thrombocytopenia.
Hematol. Oncol. Clin. North Am., Dec;23(6):1193-211 (2009)
International consensus report on the investigation and management of primary immune thrombocytopenia.
Blood., Jan;115(2):168-86 (2010)
Quantifying the reduction in immunoglobulin use over time in patients with chronic immune thrombocytopenic purpura receiving romiplostim (AMG 531).
Am. J. Hematol., Aug;84(8):538-40 (2009)
The pathophysiology of ITP revisited: ineffective thrombopoiesis and the emerging role of thrombopoietin receptor agonists in the management of chronic immune thrombocytopenic purpura.
Hematology Am Soc Hematol Educ Program., 219-26 (2008)
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial.
Lancet., Feb;371(9610):395-403 (2008)
Recipient and donor factors influence the incidence of graft-vs.-host disease in liver transplant patients.
Liver Transpl., Apr;13(4):516-22 (2007)
The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial.
Shock., Oct;26(4):342-7 (2006)